Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 11-06-2020 | Practice Area: | Corporate and M&A |
| Deal Title: | Novo Nordisk A/S Acquisition of Corvidia Therapeutics Inc. | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Davis Polk advised Novo Nordisk A/S on its acquisition of Corvidia Therapeutics Inc. for an upfront payment of USD725 million in cash. Total payments to Corvidia Therapeutics shareholders potentially ultimately amounted to USD2.1 billion in cash upon the achievement of certain regulatory and sales milestones by Novo Nordisk.
|
||
| Financial Center: | New York | Value: | 1000.01-5000.00 |
| Advised Party: | Acquiror | Law Firm | Davis Polk |
| Target Company Jurisdiction: | United States | Acquiror Jurisdiction: | Denmark |
| Classification: |
Strategic Buyer Acquisitions Private Company |
Lawyer | William H Aaronson |
